http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2526672-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80530469649bedd0a755d2f523209415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095 |
| filingDate | 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f801065fcb21eb8b72fd257808038d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10c8c9646dad1be820a3466a3773ced8 |
| publicationDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2526672-T3 |
| titleOfInvention | New uses of oxytocin-type molecules and related methods |
| abstract | A derivative selected from oxytocin, a derivative of oxytocin and an oxytocin agonist for use in the treatment of a disorder selected from obesity and insulin resistance, wherein the derivative of oxytocin is selected from 4 -treonine-1-hydroxideaminooxytocin, 4-serine, isoleucine-oxytocin-8, 9-deamidooxitocin, 7-D-proline-oxytocin, (2, 4-diisoleucine) -oxytocin, 1-deamino-1-monocarba-E12-Tir (OMe)] - OT (dCOMOT), carbetocin (SEQ ID NO .: 2: Butiril-Tir (Me) -Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2), 4-threonine, 7-glycine -oxytocin (TG-OT), (1-butanoic acid-2- (O-methyl-L-tyrosine) -1-carbaoxitocina, Ile-conopresina, atosiban, oxipresina, deamino-6-carba-oxytoxino (dC60), desmopressina and 1-deamino-oxytocin where the disulfide bridge between residues 1 and 6 is replaced by a thioether, wherein said oxytocin, derived from oxytocin or oxytocin agonist is to be administered periferally. |
| priorityDate | 2010-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 488.